BMO Capital reiterates Eli Lilly (LLY) at Outperform on Morphic deal, 'a positive for Lilly shares' Jul 8, 2024 12:29PM
Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares May 5, 2023 10:30AM
Morphic Therapeutic (MORF) Announces Proposed Public Offering May 2, 2023 04:03PM
Morphic Therapeutic Announces Proposed Public Offering May 2, 2023 04:02PM
Morphic Therapeutic (MORF) PT Raised to $106 at BMO Capital Apr 25, 2023 05:20PM


Feb 28, 2022 07:21AM Morphic Therapeutic (MORF) PT Lowered to $83 at BMO Capital
Mar 3, 2021 06:07AM Morphic Therapeutic (MORF) Prices 3.5M Share Upsized Common Offering at $70/Sh
Mar 2, 2021 08:25PM Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
Mar 2, 2021 08:25PM Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering
Mar 1, 2021 04:03PM Morphic Therapeutic (MORF) Announces $200M Proposed Public Offering of Common Stock
Mar 1, 2021 04:01PM Morphic Therapeutic Announces Proposed Public Offering
Mar 1, 2021 04:01PM Morphic Therapeutic Announces Proposed Public Offering
Mar 1, 2021 03:55PM Morphic Therapeutic (MORF) PT Raised to 'Street High' $111 at BMO Capital
Nov 9, 2020 12:07PM Morphic Therapeutic (MORF) PT Raised to $40 at BMO Capital
Aug 10, 2020 03:33PM Morphic Therapeutic (MORF) PT Raised to $37 at BMO Capital, Following Earnings
Aug 13, 2019 07:06AM Morphic Therapeutic (MORF) PT Raised to $32 at BMO Capital
Jul 22, 2019 01:57AM BMO Capital Starts Morphic Therapeutic (MORF) at Outperform
Jul 1, 2019 04:30PM Morphic Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 27, 2019 06:25AM Morphic Holding, Inc. (MORF) Prices 6M Share Upsized IPO at $15/Sh
Jun 26, 2019 08:30PM Morphic Announces Pricing of Upsized Initial Public Offering